Literature DB >> 21281634

Remyelination after olfactory ensheathing cell transplantation into diverse demyelinating environments.

Masanori Sasaki1, Karen L Lankford, Christine Radtke, Osamu Honmou, Jeffery D Kocsis.   

Abstract

Olfactory ensheathing cells (OECs) can remyelinate demyelinated spinal cord axons when transplanted into chemically induced demyelinated lesions. Cell transplantation is typically performed within a few days after lesion induction, i.e. during active demyelination when myelin debris, cytokine level increases and macrophage/microglia activation is extensive. Inflammatory signaling has been suggested to facilitate remyelination in cell transplant studies. In this review we discuss the migration and remyelination properties of OECs transplanted into various demyelinating lesion environments including conditions when inflammation is active and when it is largely subsided. While sharing many common properties, comparisons of the in vivo fate between OECs and SCs suggest unique properties of OECs as compared to SCs. A complicating factor in the assessment of experimental remyelination by transplantation of myelin-forming cells in general is the rapidity of endogenous myelin repair in most rodent models of demyelination. Alternative persistent demyelination models are discussed as potential tools to study both the competency of chronic demyelinated axons for remyelination and the remyelination potential of cells such as human progenitors that require longer times to mobilize and remyelinate axons. This article is part of a Special Issue entitled: Understanding olfactory ensheathing glia and their prospect for nervous system repair. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21281634     DOI: 10.1016/j.expneurol.2011.01.010

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  18 in total

1.  Effect of Some Growth Factors on Tissue Transglutaminase Overexpression Induced by β-Amyloid in Olfactory Ensheathing Cells.

Authors:  Rosalia Pellitteri; Roberta Bonfanti; Michela Spatuzza; Maria Teresa Cambria; Mariacristina Ferrara; Giuseppina Raciti; Agata Campisi
Journal:  Mol Neurobiol       Date:  2016-10-18       Impact factor: 5.590

Review 2.  Biological roles of olfactory ensheathing cells in facilitating neural regeneration: a systematic review.

Authors:  Hao Yang; Bao-Rong He; Ding-Jun Hao
Journal:  Mol Neurobiol       Date:  2014-03-11       Impact factor: 5.590

Review 3.  Myelin status and oligodendrocyte lineage cells over time after spinal cord injury: What do we know and what still needs to be unwrapped?

Authors:  Nicole Pukos; Matthew T Goodus; Fatma R Sahinkaya; Dana M McTigue
Journal:  Glia       Date:  2019-08-24       Impact factor: 7.452

4.  Engineering an in situ crosslinkable hydrogel for enhanced remyelination.

Authors:  Xiaowei Li; Xiaoyan Liu; Lin Cui; Christopher Brunson; Wen Zhao; Narayan R Bhat; Ning Zhang; Xuejun Wen
Journal:  FASEB J       Date:  2012-12-13       Impact factor: 5.191

5.  The wmN1 enhancer region in intron 1 is required for expression of human PLP1.

Authors:  Hamdan Hamdan; Pankaj Patyal; Neriman T Kockara; Patricia A Wight
Journal:  Glia       Date:  2018-04-23       Impact factor: 7.452

Review 6.  Cell-based reparative therapies for multiple sclerosis.

Authors:  Tamir Ben-Hur; Nina Fainstein; Yossi Nishri
Journal:  Curr Neurol Neurosci Rep       Date:  2013-11       Impact factor: 5.081

Review 7.  Immune responses in the injured olfactory and gustatory systems: a role in olfactory receptor neuron and taste bud regeneration?

Authors:  Hari G Lakshmanan; Elayna Miller; AnnElizabeth White-Canale; Lynnette P McCluskey
Journal:  Chem Senses       Date:  2022-01-01       Impact factor: 4.985

8.  Phenotypic Modulation and Neuroprotective Effects of Olfactory Ensheathing Cells: a Promising Tool for Cell Therapy.

Authors:  Rosalia Pellitteri; Lidia Cova; Damiano Zaccheo; Vincenzo Silani; Patrizia Bossolasco
Journal:  Stem Cell Rev Rep       Date:  2016-04       Impact factor: 5.739

9.  Autologous olfactory mucosal cell transplants in clinical spinal cord injury: a randomized double-blinded trial in a canine translational model.

Authors:  Nicolas Granger; Helen Blamires; Robin J M Franklin; Nick D Jeffery
Journal:  Brain       Date:  2012-11       Impact factor: 13.501

Review 10.  Cell therapy and delivery strategies for spinal cord injury.

Authors:  Bruna Dos S Ramalho; Fernanda M de Almeida; Ana M B Martinez
Journal:  Histol Histopathol       Date:  2021-06-10       Impact factor: 2.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.